27017-64-7Relevant articles and documents
A novel bis-lactam acceptor with outstanding molar extinction coefficient and structural planarity for donor-acceptor type conjugated polymer
Yoon, Won Sik,Kim, Dong Won,Park, Jun-Mo,Cho, Illhun,Kwon, Oh Kyu,Whang, Dong Ryeol,Kim, Jin Hong,Park, Jung-Hwa,Park, Soo Young
, p. 8489 - 8497 (2016/12/03)
A novel electron-accepting bis-lactam building block, 3,7-dithiophen-2-yl-1,5-dialkyl-1,5-naphthyridine-2,6-dione (NTDT), and a conjugated polymer P(NTDT-BDT) comprising NTDT as an electron acceptor and benzo[1,2-b:4,5-b′]dithiophene (BDT) as an electron donor are designed and synthesized for producing efficient organic solar cells. The thermal, electronic, photophysical, electrochemical, and structural characteristics of NTDT and P(NTDT-BDT) are studied in detail and compared with those of the widely used bis-lactam acceptor 3,6-dithiophen-2-yl-2,5-dialkylpyrrolo[3,4-c]pyrrole-1,4-dione (DPPT) and its polymer P(DPPT-BDT). Compared to DPPT derivatives, NTDT and P(NTDT-BDT) exhibit remarkably higher absorption coefficients, deeper highest occupied molecular orbital energy levels, and more planar conformations. A bulk heterojunction solar cells based on P(NTDT-BDT) exhibit power conversion efficiency of up to 8.16% with high short circuit current (Jsc) of 18.51 mA cm-2, one of the highest Jsc values yet obtained for BDT-based polymer. Thus, it is successfully demonstrated that the novel bis-lactam unit NTDT is a promising building block for use in organic photovoltaic devices.
Novel N-linked aminopiperidine-based gyrase inhibitors with improved hERG and in vivo efficacy against mycobacterium tuberculosis
Hameed P, Shahul,Patil, Vikas,Solapure, Suresh,Sharma, Umender,Madhavapeddi, Prashanti,Raichurkar, Anandkumar,Chinnapattu, Murugan,Manjrekar, Praveena,Shanbhag, Gajanan,Puttur, Jayashree,Shinde, Vikas,Menasinakai, Sreenivasaiah,Rudrapatana, Suresh,Achar, Vijayashree,Awasthy, Disha,Nandishaiah, Radha,Humnabadkar, Vaishali,Ghosh, Anirban,Narayan, Chandan,Ramya,Kaur, Parvinder,Sharma, Sreevalli,Werngren, Jim,Hoffner, Sven,Panduga, Vijender,Kumar, C. N. Naveen,Reddy, Jitendar,Kumar Kn, Mahesh,Ganguly, Samit,Bharath, Sowmya,Bheemarao, Ugarkar,Mukherjee, Kakoli,Arora, Uma,Gaonkar, Sheshagiri,Coulson, Michelle,Waterson, David,Sambandamurthy, Vasan K.,De Sousa, Sunita M.
supporting information, p. 4889 - 4905 (2014/07/07)
DNA gyrase is a clinically validated target for developing drugs against Mycobacterium tuberculosis (Mtb). Despite the promise of fluoroquinolones (FQs) as anti-tuberculosis drugs, the prevalence of pre-existing resistance to FQs is likely to restrict their clinical value. We describe a novel class of N-linked aminopiperidinyl alkyl quinolones and naphthyridones that kills Mtb by inhibiting the DNA gyrase activity. The mechanism of inhibition of DNA gyrase was distinct from the fluoroquinolones, as shown by their ability to inhibit the growth of fluoroquinolone-resistant Mtb. Biochemical studies demonstrated this class to exert its action via single-strand cleavage rather than double-strand cleavage, as seen with fluoroquinolones. The compounds are highly bactericidal against extracellular as well as intracellular Mtb. Lead optimization resulted in the identification of potent compounds with improved oral bioavailability and reduced cardiac ion channel liability. Compounds from this series are efficacious in various murine models of tuberculosis.
